cystamine hydrochloride has been researched along with carboxyamido-triazole in 1 studies
| Studies (cystamine hydrochloride) | Trials (cystamine hydrochloride) | Recent Studies (post-2010) (cystamine hydrochloride) | Studies (carboxyamido-triazole) | Trials (carboxyamido-triazole) | Recent Studies (post-2010) (carboxyamido-triazole) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 105 | 15 | 22 |
| Protein | Taxonomy | cystamine hydrochloride (IC50) | carboxyamido-triazole (IC50) |
|---|---|---|---|
| galanin receptor type 3 | Homo sapiens (human) | 1.8696 | |
| COUP transcription factor 2 isoform a | Homo sapiens (human) | 9.206 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Ding, HF; Lang, L; Liu, G; Sun, SY; Yan, C | 1 |
1 other study(ies) available for cystamine hydrochloride and carboxyamido-triazole
| Article | Year |
|---|---|
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
Topics: CRISPR-Cas Systems; Gene Targeting; Genes; Genes, Reporter; Genetic Engineering; Humans; Internal Ribosome Entry Sites; Transcription, Genetic | 2015 |